Overview
What is Patients For Affordable Drugs?
Patients For Affordable Drugs is a financially independent, patient-centric nonprofit organization, situated in Washington, D.C. Their primary mission is to advocate for affordable drug prices, educating the public, patients, and key stakeholders about the challenges associated with the current drug development and pricing framework. By raising the voices of patients and their families, this organization aims to empower them to participate in discussions and work towards reforms in both the private and public sectors of drug pricing in the United States. The nonprofit operates with 14 employees, dedicated to promoting health and addressing the concerns of individuals affected by high drug prices.
Official website here: www.patientsforaffordabledrugs.org
Is Patients For Affordable Drugs legitimate?
Patients For Affordable Drugs is a legitimate nonprofit organization registered as a 501(c)(3) entity. Patients For Affordable Drugs submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $281,252
Professional Fundraising Fees: $0
Other Salaries and Wages: $330,465
For more financial information, click here
What is the mission statement of Patients For Affordable Drugs?
Patients For Affordable Drugs is an organization with a mission to promote health by advocating for patients and their families on the issue of high drug prices. Their goal is to educate these individuals about their role in the discussion and work towards reforming the drug pricing system in both the private and public sectors in the United States. The organization's general program involves building a patient-centered coalition that is financially independent from any pharmaceutical industry support, with the aim of educating the public, patients, and key stakeholders about the challenges patients face under the current drug development and pricing framework.
Official website here: www.patientsforaffordabledrugs.org
Who is the CEO of Patients For Affordable Drugs?
David Mitchell is the Chief Operating Officer of Patients For Affordable Drugs.
Official website here: www.patientsforaffordabledrugs.org
What is the revenue of Patients For Affordable Drugs?
Patients For Affordable Drugs's revenue in 2021 was $603,423.
Official website here: www.patientsforaffordabledrugs.org
Who are the executives of Patients For Affordable Drugs and what are their salaries?
The average compensation at Patients For Affordable Drugs during 2021 was $43,694. There are 14 employees and 5 volunteers at Patients For Affordable Drugs.
Here are 9 key members and their salaries:
- Wendy Chew (Chief Operating Officer)
- Lucy Westerfield (Deputy Executive Director)
- Sarah Kaminer Bourland (Legislative Director)
- Sheila Mclean (Executive Director)
- David Mitchell (President/Founder) [Trustee/Director]
- Cal Laroche (Treasurer) [Trustee/Director]
- Charles Hurley (Board Member) [Trustee/Director]
- Tomi Fadeyi-Jones (Board Member) [Trustee/Director]
- Nicole Solomon Mitchell (Board Member) [Trustee/Director]
Official website here: www.patientsforaffordabledrugs.org
Where can I find the form 990 for Patients For Affordable Drugs?
The Patients For Affordable Drugs’s most recent form 990 was submitted in 2021 and can be accessed here
Official website here: www.patientsforaffordabledrugs.org
Learn more at the official website: www.patientsforaffordabledrugs.org
Mission Statement of Patients For Affordable Drugs
Patients For Affordable Drugs, a patient-centered coalition, aims to promote health and wellbeing by elevating the voices of patients and their families in the discourse surrounding the high costs of prescription drugs. This nonprofit organization strives to educate these individuals about their role in shaping reforms to the United States' drug pricing system, both in the private and public sectors. The coalition's mission is to build a financially independent network, free from pharmaceutical industry support, that advocates for public awareness and engagement in the challenges patients face under the current drug development and pricing framework. By doing so, Patients For Affordable Drugs seeks to foster a more equitable and accessible drug pricing landscape for all.
Impact
This information is meant to be a general summary of Patients For Affordable Drugs. Please take the time to review official sources before making any decisions based upon the content provided here.
Wednesday, July 24, 2024
Patients For Affordable Drugs has made a significant impact by advocating for lower drug prices and raising awareness about the challenges patients face due to high drug costs. Through their patient-centered coalition, they have empowered individuals to be part of the discussion on drug pricing reforms in both the private and public sectors. By amplifying the voices of patients and their families, Patients For Affordable Drugs has helped drive changes in the US healthcare system to make medications more accessible and affordable for all.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2021.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONSULTING
Revenue
$25,000
Organization Details
Founding Year
2016
Phone
(202) 734-7555
Principal Officer
David Mitchell
Main Address
1120 20TH ST NW SUITE 501-S, WASHINGTON, DC, 20036
NTEE Category
Code: E01 - Health
If you are a representative of Patients For Affordable Drugs and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.